BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 28393233)

  • 1. Assessment of Th17 lymphocytes and cytokine IL‑17A in epithelial ovarian tumors.
    Winkler I; Pyszniak M; Pogoda K; Semczuk A; Gogacz M; Miotla P; Adamiak A; Darmochwal-Kolarz D; Rechberger T; Tabarkiewicz J
    Oncol Rep; 2017 May; 37(5):3107-3115. PubMed ID: 28393233
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulatory T lymphocytes and transforming growth factor beta in epithelial ovarian tumors-prognostic significance.
    Winkler I; Wilczynska B; Bojarska-Junak A; Gogacz M; Adamiak A; Postawski K; Darmochwal-Kolarz D; Rechberger T; Tabarkiewicz J
    J Ovarian Res; 2015 Jun; 8():39. PubMed ID: 26077607
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IL-17A is elevated in sera of patients with poorly differentiated ovarian papillary serous cystadenocarcinoma.
    Malekzadeh M; Dehaghani AS; Ghaderi A; Doroudchi M
    Cancer Biomark; 2013 Jan; 13(6):417-25. PubMed ID: 24595078
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An association of circulating Tregs and Th17 cells producing IL-21 and IL-22 with the ROMA in ovarian cancer patients.
    Winkler I; Woś J; Karczmarczyk A; Miotła P; Gogacz M; Skorupska K; Rechberger T; Tabarkiewicz J; Wolińska E; Skrzypczak M
    Cytokine; 2020 Oct; 134():155194. PubMed ID: 32707423
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Implication of IL-17 producing ɑβT and γδT cells in patients with ovarian cancer.
    Chen X; Zhang X; Xu R; Shang W; Ming W; Wang F; Wang J
    Hum Immunol; 2020 May; 81(5):244-248. PubMed ID: 32093885
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immune response evaluation through determination of type 1, type 2, and type 17 patterns in patients with epithelial ovarian cancer.
    Cândido EB; Silva LM; Carvalho AT; Lamaita RM; Filho RM; Cota BD; da Silva-Filho AL
    Reprod Sci; 2013 Jul; 20(7):828-37. PubMed ID: 23239818
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of Th17 cells in patients with relapsing-remitting multiple sclerosis: interleukin-17A and interleukin-17F serum levels.
    Babaloo Z; Aliparasti MR; Babaiea F; Almasi S; Baradaran B; Farhoudi M
    Immunol Lett; 2015 Apr; 164(2):76-80. PubMed ID: 25625963
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Colorectal cancer progression is associated with accumulation of Th17 lymphocytes in tumor tissues and increased serum levels of interleukin-6.
    Li X; Wang Y; Han C; Li P; Zhang H
    Tohoku J Exp Med; 2014 Jul; 233(3):175-82. PubMed ID: 24990228
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Evaluation of the intracellular expression of interleukin 17 in patients with ovarian cancer].
    Rogala E; Nowicka A; Bednarek W; Barczyński B; Wertel I; Zakrzewski M; Kotarski J
    Ginekol Pol; 2012 Jun; 83(6):424-8. PubMed ID: 22880461
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IL-17A-producing T cells and associated cytokines are involved in the progression of gastric cancer.
    Zhong F; Cui D; Tao H; Du H; Xing C
    Oncol Rep; 2015 Nov; 34(5):2365-74. PubMed ID: 26352729
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of Th22, Th17 and CD4
    Doulabi H; Rastin M; Shabahangh H; Maddah G; Abdollahi A; Nosratabadi R; Esmaeili SA; Mahmoudi M
    Biomed Pharmacother; 2018 Jul; 103():1101-1106. PubMed ID: 29710675
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FoxP3+ regulatory T cells in peripheral blood of patients with epithelial ovarian cancer.
    Erfani N; Hamedi-Shahraki M; Rezaeifard S; Haghshenas M; Rasouli M; Samsami Dehaghani A
    Iran J Immunol; 2014 Jun; 11(2):105-12. PubMed ID: 24975967
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased frequency of circulating Th22 in addition to Th17 and Th2 lymphocytes in systemic sclerosis: association with interstitial lung disease.
    Truchetet ME; Brembilla NC; Montanari E; Allanore Y; Chizzolini C
    Arthritis Res Ther; 2011; 13(5):R166. PubMed ID: 21996293
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical significance of IL-23 regulating IL-17A and/or IL-17F positive Th17 cells in chronic periodontitis.
    Luo Z; Wang H; Wu Y; Sun Z; Wu Y
    Mediators Inflamm; 2014; 2014():627959. PubMed ID: 25525302
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IL-21 induction of CD4+ T cell differentiation into Th17 cells contributes to bleomycin-induced fibrosis in mice.
    Lei L; Zhong XN; He ZY; Zhao C; Sun XJ
    Cell Biol Int; 2015 Apr; 39(4):388-99. PubMed ID: 25492803
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of peripheral Th17 lymphocytes in patients with asthma.
    Wong CK; Lun SW; Ko FW; Wong PT; Hu SQ; Chan IH; Hui DS; Lam CW
    Immunol Invest; 2009; 38(7):652-64. PubMed ID: 19811428
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interaction between Treg cells and tumor-associated macrophages in the tumor microenvironment of epithelial ovarian cancer.
    Zhu Q; Wu X; Wu Y; Wang X
    Oncol Rep; 2016 Dec; 36(6):3472-3478. PubMed ID: 27748885
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma endothelial protein C receptor influences innate immune response in ovarian cancer by decreasing the population of natural killer and TH17 helper cells.
    Azzazene D; Al Thawadi H; Al Farsi H; Besbes S; Geyl C; Mirshahi S; Pardo J; Faussat AM; Jeannette S; Therwath A; Pujade-Lauraine E; Mirshahi M
    Int J Oncol; 2013 Oct; 43(4):1011-8. PubMed ID: 23877403
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of T-helper 17 cell related cytokines in laryngeal cancer.
    Muderris TK; Gul F; Doblan A; Ergin M; Muderris T
    J Laryngol Otol; 2019 May; 133(5):394-398. PubMed ID: 31006415
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Do Th17 cells play an important role in the pathogenesis and prognosis of ovarian cancer?].
    Winkler I; Gogacz M; Rechberger T
    Ginekol Pol; 2012 Apr; 83(4):295-300. PubMed ID: 22712263
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.